Ultralife (NASDAQ:ULBI) Director Bradford Whitmore Buys 32,876 Shares of Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore purchased 32,876 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was acquired at an average price of $6.13 per share, for a total transaction of $201,529.88. Following the completion of the transaction, the director owned 1,974,635 shares of the company’s stock, valued at $12,104,512.55. This represents a 1.69% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Ultralife Price Performance

Shares of Ultralife stock opened at $6.86 on Wednesday. The company has a current ratio of 2.56, a quick ratio of 1.23 and a debt-to-equity ratio of 0.34. The company’s 50-day moving average price is $6.75 and its two-hundred day moving average price is $6.23. Ultralife Corporation has a 52 week low of $4.90 and a 52 week high of $9.52. The stock has a market cap of $114.29 million, a PE ratio of -13.72 and a beta of 0.74.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings results on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.15 by ($0.18). Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.The business had revenue of $47.45 million during the quarter, compared to the consensus estimate of $52.40 million.

Institutional Investors Weigh In On Ultralife

Several hedge funds and other institutional investors have recently bought and sold shares of ULBI. Bank of America Corp DE raised its position in Ultralife by 30.7% in the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock worth $90,000 after acquiring an additional 2,836 shares in the last quarter. Jones Financial Companies Lllp raised its position in Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after acquiring an additional 14,287 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in Ultralife by 474.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 70,476 shares of the technology company’s stock worth $633,000 after acquiring an additional 58,211 shares in the last quarter. Walleye Capital LLC raised its position in Ultralife by 127.2% in the second quarter. Walleye Capital LLC now owns 31,102 shares of the technology company’s stock worth $279,000 after acquiring an additional 17,414 shares in the last quarter. Finally, Qube Research & Technologies Ltd bought a new stake in Ultralife in the second quarter worth about $134,000. 30.68% of the stock is currently owned by institutional investors.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.